Global Comparative Effectiveness Research

Use of Comparative Effectiveness Research in Drug Coverage and Pricing Decisions: A Six Country Comparison
The Commonwealth Fund | July 2, 2010
Corinna Sorenson of the London School of Economics examines the use of CER in six countries—Denmark, England, France, Germany, the Netherlands, and Sweden.

Comparative Effectiveness Research: International Experiences and Implications for the United States
Academy Health | July 2009
This report looks at how CER programs operate in other countries and how they address important policy issues.

Austria

Health Care Systems Road Map--Pharmaceuticals
ISPOR
An overview of the Austrian health care delivery system with a focus on the reimbursement and pricing approval processes for pharmaceuticals, medical devices, and diagnostics.

Denmark

Health Care Systems Road Map--Pharmaceuticals
ISPOR
An overview of Denmark’s health care delivery system with a focus on the reimbursement and pricing approval processes for pharmaceuticals, medical devices, and diagnostics.

France

Health Care Systems Road Map—Pharmaceuticals
Health Care Systems Road Map—Medical Devices and Diagnostics
ISPOR
An overview of France’s health care delivery system with a focus on the reimbursement and pricing approval processes for pharmaceuticals, medical devices, and diagnostics.

Haute Autorité de Santé
The French National Authority for Health’s Evaluation Committee for Medical Products is an independent public body that makes coverage and pricing recommendations to the Ministry of Health.

Germany

Health Care Systems Road Map
ISPOR
An overview of Germany’s health care delivery system with a focus on the reimbursement and pricing approval processes for pharmaceuticals, medical devices, and diagnostics.

Germany's IQWiG Calls for Wider Availability of Comparative Effectiveness Data
The Pink Sheet Daily | October 14, 2010
Proposals in Germany to prioritize more use of CER to cut drug costs prompted IQWiG (Germany's cost-effectiveness body) to call for the data to be made more available to doctors and patients.

Institute for Quality and Efficiency in Health Care (IQWiG)
Germany’s CER body which serves an advisory role, making coverage and pricing recommendations to the Federal Joint Commission and the Ministry of Health.

Italy

Health Care Systems Road Map—Pharmaceuticals
ISPOR
An overview of Italy’s health care delivery system with a focus on the reimbursement and pricing approval processes for pharmaceuticals, medical devices, and diagnostics.

The Netherlands

Health Care Systems Road Map—Pharmaceuticals
ISPOR
An overview of the Netherlands’ health care delivery system with a focus on the reimbursement and pricing approval processes for pharmaceuticals, medical devices, and diagnostics.

United Kingdom

Health Care Systems Road Map—Pharmaceuticals
Health Care Systems Road Map—Diagnostics
ISPOR
An overview of the UK’s health care delivery system with a focus on the reimbursement and pricing approval processes for pharmaceuticals, medical devices, and diagnostics.

National Institute for Health and Clinical Excellence (NICE)
NICE provides guidance, sets quality standards, and manages a national database to improve people’s health and prevent and treat ill health in the United Kingdom.

From Research to Health Care Practice: How the UK Uses Data on Comparative Effectiveness
JAMA | September 8, 2010
A look at how the National Institute for Health and Clinical Excellence (NICE) develops comparative effectiveness data, assesses it, and translates it into policy.
NICE: How Does it Work and What Are the Implications for the U.S?
National Pharmaceutical Council | May 2008
This studies authors--Sorendon, Drummond, Kanavos, and McGuire--examine key learnings from NICE, and overview of its operations, and implications for CER in the U.S.

United States

AHRQ's Role in Advancing CER: State-of-the-Art Methods and Data Sources
Carolyn Clancy, AHRQ | June 15, 2010
In her presentation a Lewin Group symposium on CER, AHRQ Director outlines AHRQ's role in CER.

CER Inventory from the Partnership to Improve Patient Care (PIPC)
PIPC
Comprehensive source for federally sponsored CER.

GAO Announces Appointments to New Patient-Centered Outcomes Research Institute (PCORI) Board of Governors
GAO | September 23, 2010
The U.S. Government Accountability Office announced the appointment of 19 members to the Board of Governors for the new Patient-Centered Outcomes Research Institute.

The Implications of Comparative Effectiveness for Medicare
Center for Studying Health System Change | September 14, 2010
In her presentation at The Second National Comparative Effectiveness Summit, Elizabeth Docteaur discusses CER and Medicare and how the latest CER initiatives could impact Medicare policies.